Research programme: ion-channel modulators - Saniona
Alternative Names: KV7 ion channel modulatorsLatest Information Update: 22 Aug 2022
At a glance
- Originator BenevolentAI; Saniona
- Class Analgesics; Antiepileptic drugs; Small molecules; Urologics
- Mechanism of Action Kv channel-interacting protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Epilepsy
- No development reported Pain; Urinary incontinence